RESEARCH & DEVELOPMENT AT BIO-MED
The development of technology for manufacturing vaccines by the in-house
Research and Development team of scientists and technicians has been the
hallmark at Bio-Med’s R & D laboratories.
Bio-Med has succeeded in developing technologies of over 10 human vaccines
in its R & D laboratories — most of them launched for the first time in India
and of world-class quality. USP vaccines have shown least reactogenicity
and good potency.
Complex technologies for manufacturing vaccines and active biomolecules
have been developed with technical guidance from research institutions
in the U.S.A., Germany, and Switzerland.
Bio-Med’s R & D laboratories are accredited by DSIR, Government of India.